The Progressive Conservatives’ landslide victory in last week’s provincial election has many of us wondering what’s next. Can this historic shift in power bring social and fiscal policies into balance, or will it trigger an extreme swing of the pendulum? And what does this all mean for our life sciences…
Melissa Hughes
At the opening of Toronto Health Innovation Week this spring, MaRS Discovery District CEO Yung Wu had this to say about our health and life sciences ecosystem: “We have been through crawling and walking, now we are starting to run and sprint.” Indeed, 2018 represents a crossroads for our sector….
PARIS — Sanofi is investing €350 million (CAD $500 million) for the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. The investment bolsters the company’s Canadian operations and its commitment to advancing public health around the world. The announcement will be made…
Life Sciences Ontario welcomes the provincial budget released yesterday, including key investments in post-secondary education, healthcare system innovation, and leveraging our ability to attract and retain investment in Ontario’s life sciences sector. The provincial government’s commitment of $50 million for a dedicated life sciences venture fund demonstrates this recognition of our sector…
New financial contribution will bring total IRAP conditional funding support to $1.48 million December 12, 2016 GUELPH, Ont., CANADA— PlantForm Corporation is advancing its work on innovative antibody treatments for human immunodeficiency virus (HIV) with a financial contribution of up to $117,400 and technical and business advisory services from the…
Earlier this month, the Patented Medicine Prices Review Board published new regulations that could see drug prices cut by up to 20 per cent. Taking a page from United States President Donald Trump, Prime Minister Justin Trudeau’s government has adopted a reductive, fair-means-cheap pricing equation. The effects may be damaging…
TORONTO– LSO today announced the recipients of its 2018 LSO Awards, recognizing outstanding individuals and companies contributing to the success of Ontario’s life sciences sector. The awards will be presented during LSO’s Celebration of Success Awards Dinner at Toronto’s Liberty Grand, February 28, 2018. The 2018 awardees are as follows:…
Toronto, Ontario – Cyclica, an in silico drug discovery company that offers a novel proteome-wide screening predictive analytics platform for the pharmaceutical and related industries, has been recognized by Corporate LiveWire Magazine in their 2016 Healthcare and Life Sciences Award series in the category of “Excellence in Life Saving Therapeutics.”…
Ontario has appointed Molly Shoichet to advance science and innovation in the province — and to make government smarter and more effective by providing decision-makers with the world’s best scientific research and evidence. The Chief Scientist will advise Premier Kathleen Wynne directly on key scientific matters, demonstrating Ontario’s ongoing commitment…
Eurofins Scientific (Paris:ERF) (EUFI.PA), a world leader in biopharmaceutical testing, announces the acquisition of Alphora Research Inc. (“Alphora”), a full service contract research, development and manufacturing organization (CRDMO) for complex and niche small molecule active pharmaceutical ingredients (APIs), based in Mississauga, Ontario, Canada. Alphora has extensive capabilities in multi-step syntheses,…